The UK Supreme Court has clarified the extent of a doctor's duty to inform patients about alternative treatments, ruling in McCulloch v Forth Valley Health Board that clinicians are not legally required to discuss options they reasonably consider medically inappropriate. The unanimous judgment addresses a question left open by earlier consent case law and sets a clearer boundary around what practitioners must place before patients when securing informed consent.
The case in brief
The claim arose from the death of Neil McCulloch, who suffered a cardiac arrest in April 2012 at Forth Valley Royal Hospital in Scotland. His family argued that a consultant cardiologist, Dr Catherine Labinjoh, had failed to discuss non-steroidal anti-inflammatory drugs as a possible treatment for pericarditis. The central legal question was whether a doctor must raise a treatment option they personally judge to be clinically inappropriate, in circumstances where a separate body of medical opinion might support that alternative.
What the court decided
The Supreme Court held that doctors are not legally required to discuss treatment options they do not regard as medically appropriate, provided that assessment is capable of support under established professional practice standards. In other words, the threshold question of whether an alternative treatment is "reasonable" is a matter of clinical judgment, informed by responsible medical opinion, rather than something imposed on the clinician after the event.
How it fits with Montgomery and Bolitho
The ruling refines rather than displaces the landmark decision in Montgomery v Lanarkshire Health Board, which established that doctors must disclose material risks and reasonable alternative treatments so that patients can make informed choices. McCulloch clarifies the earlier stage of that analysis: whether an option counts as a "reasonable alternative" in the first place depends on professional clinical judgment supported by a responsible body of medical opinion. The court also preserved the effect of Bolitho v City and Hackney Health Authority, under which judges may still reject a professional opinion that cannot withstand logical scrutiny, ensuring clinical reasoning remains open to challenge.
What it means for clinicians and providers
In practice, doctors must continue to disclose material risks and genuinely reasonable alternatives, but they retain professional responsibility for determining which options qualify as medically reasonable. The decision places a premium on documentation. Healthcare organisations are expected to record clinical reasoning and treatment-option assessments thoroughly, so that decisions about what was, and was not, discussed can be evidenced later. Consent governance, multidisciplinary communication and the framing of expert evidence are all likely to be reviewed in light of the judgment.
The wider significance of McCulloch lies in where it directs the focus of future litigation. Rather than asking whether every conceivable treatment was mentioned, courts will increasingly examine whether a provider can demonstrate a defensible, well-reasoned clinical process. For patients, the decision maintains the emphasis on informed choice established by Montgomery while recognising the professional expertise that shapes it. For clinicians, insurers and healthcare bodies across the United Kingdom, it signals that robust record-keeping and clearly articulated clinical reasoning will be central to defending consent-related claims in the years ahead.
